annual FCF:
-$37.85M+$11.44M(+23.21%)Summary
- As of today (September 16, 2025), XERS annual free cash flow is -$37.85 million, with the most recent change of +$11.44 million (+23.21%) on December 31, 2024.
- During the last 3 years, XERS annual FCF has risen by +$58.77 million (+60.83%).
- XERS annual FCF is now -134.77% below its all-time high of -$16.12 million, reached on December 31, 2016.
Performance
XERS Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$97.00K+$9.95M(+99.03%)Summary
- As of today (September 16, 2025), XERS quarterly free cash flow is -$97.00 thousand, with the most recent change of +$9.95 million (+99.03%) on June 30, 2025.
- Over the past year, XERS quarterly FCF has increased by +$10.65 million (+99.10%).
- XERS quarterly FCF is now -101.32% below its all-time high of $7.34 million, reached on December 31, 2023.
Performance
XERS quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$16.78M+$10.65M(+38.82%)Summary
- As of today (September 16, 2025), XERS TTM free cash flow is -$16.78 million, with the most recent change of +$10.65 million (+38.82%) on June 30, 2025.
- Over the past year, XERS TTM FCF has increased by +$22.05 million (+56.79%).
- XERS TTM FCF is now -334.55% below its all-time high of -$3.86 million, reached on March 31, 2017.
Performance
XERS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
XERS Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.2% | +99.1% | +56.8% |
| 3 y3 years | +60.8% | +99.5% | +86.2% |
| 5 y5 years | +64.1% | +99.6% | +85.2% |
XERS Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +63.4% | -101.3% | +99.6% | at high | +86.2% |
| 5 y | 5-year | at high | +64.1% | -101.3% | +99.8% | at high | +86.2% |
| alltime | all time | -134.8% | +64.1% | -101.3% | +99.8% | -334.6% | +86.2% |
XERS Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$97.00K(-99.0%) | -$16.78M(-38.8%) |
| Mar 2025 | - | -$10.04M(-672.3%) | -$27.43M(-27.5%) |
| Dec 2024 | -$37.85M(-23.2%) | $1.75M(-120.9%) | -$37.85M(+17.3%) |
| Sep 2024 | - | -$8.39M(-21.9%) | -$32.27M(-16.9%) |
| Jun 2024 | - | -$10.74M(-47.5%) | -$38.83M(-10.5%) |
| Mar 2024 | - | -$20.47M(-378.9%) | -$43.38M(-12.0%) |
| Dec 2023 | -$49.29M(-52.3%) | $7.34M(-149.1%) | -$49.29M(-32.4%) |
| Sep 2023 | - | -$14.96M(-2.2%) | -$72.88M(-3.9%) |
| Jun 2023 | - | -$15.29M(-42.0%) | -$75.85M(-6.8%) |
| Mar 2023 | - | -$26.38M(+62.3%) | -$81.38M(-21.3%) |
| Dec 2022 | -$103.42M(+7.0%) | -$16.25M(-9.4%) | -$103.42M(-11.0%) |
| Sep 2022 | - | -$17.93M(-13.9%) | -$116.24M(-4.1%) |
| Jun 2022 | - | -$20.82M(-57.0%) | -$121.23M(+0.5%) |
| Mar 2022 | - | -$48.41M(+66.5%) | -$120.64M(+24.9%) |
| Dec 2021 | -$96.62M | -$29.08M(+26.9%) | -$96.62M(+22.9%) |
| Sep 2021 | - | -$22.92M(+13.2%) | -$78.64M(+8.2%) |
| Jun 2021 | - | -$20.24M(-17.0%) | -$72.68M(-4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$24.39M(+119.8%) | -$76.35M(-5.7%) |
| Dec 2020 | -$80.94M(-23.3%) | -$11.09M(-34.6%) | -$80.94M(-18.8%) |
| Sep 2020 | - | -$16.96M(-29.0%) | -$99.66M(-12.3%) |
| Jun 2020 | - | -$23.91M(-17.5%) | -$113.64M(+0.5%) |
| Mar 2020 | - | -$28.97M(-2.8%) | -$113.07M(+7.2%) |
| Dec 2019 | -$105.45M(+82.5%) | -$29.82M(-3.7%) | -$105.45M(+11.9%) |
| Sep 2019 | - | -$30.95M(+32.7%) | -$94.22M(+17.8%) |
| Jun 2019 | - | -$23.33M(+9.3%) | -$79.96M(+12.6%) |
| Mar 2019 | - | -$21.35M(+14.9%) | -$71.00M(+22.9%) |
| Dec 2018 | -$57.79M(+127.8%) | -$18.59M(+11.4%) | -$57.79M(+19.1%) |
| Sep 2018 | - | -$16.69M(+16.1%) | -$48.54M(+29.6%) |
| Jun 2018 | - | -$14.38M(+76.7%) | -$37.45M(+62.3%) |
| Mar 2018 | - | -$8.14M(-12.8%) | -$23.08M(+22.8%) |
| Dec 2017 | -$25.36M(+57.3%) | -$9.34M(+66.7%) | -$18.80M(+98.7%) |
| Sep 2017 | - | -$5.60M(+45.1%) | -$9.46M(+145.1%) |
| Mar 2017 | - | -$3.86M | -$3.86M |
| Dec 2016 | -$16.12M | - | - |
FAQ
- What is Xeris Biopharma Holdings, Inc. annual free cash flow?
- What is the all time high annual FCF for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. annual FCF year-on-year change?
- What is Xeris Biopharma Holdings, Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. quarterly FCF year-on-year change?
- What is Xeris Biopharma Holdings, Inc. TTM free cash flow?
- What is the all time high TTM FCF for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. TTM FCF year-on-year change?
What is Xeris Biopharma Holdings, Inc. annual free cash flow?
The current annual FCF of XERS is -$37.85M
What is the all time high annual FCF for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high annual free cash flow is -$16.12M
What is Xeris Biopharma Holdings, Inc. annual FCF year-on-year change?
Over the past year, XERS annual free cash flow has changed by +$11.44M (+23.21%)
What is Xeris Biopharma Holdings, Inc. quarterly free cash flow?
The current quarterly FCF of XERS is -$97.00K
What is the all time high quarterly FCF for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high quarterly free cash flow is $7.34M
What is Xeris Biopharma Holdings, Inc. quarterly FCF year-on-year change?
Over the past year, XERS quarterly free cash flow has changed by +$10.65M (+99.10%)
What is Xeris Biopharma Holdings, Inc. TTM free cash flow?
The current TTM FCF of XERS is -$16.78M
What is the all time high TTM FCF for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high TTM free cash flow is -$3.86M
What is Xeris Biopharma Holdings, Inc. TTM FCF year-on-year change?
Over the past year, XERS TTM free cash flow has changed by +$22.05M (+56.79%)